Uncategorized - July 3, 2014
Uppsala University gets major funding to recruit international professor
The Swedish Research Council has granted Uppsala University SEK 145 million to recruit Elisabetta Dejana, an internationally wellknown professor within vascular biology. Elisabetta Dejana is a worldleading and highly quoted researcher and is currently Professor of General Pathology at the Department of Biosciences, University of Milan. With the recruit, Uppsala University hopes to strengthen its […]
Collaboration - July 2, 2014
Cobra Biologics and QuiaPEG collaborate
Contract Manufacturing Organisation Cobra Biologics and biotech company QuiaPEG Pharmaceuticals AB have announced a strategic alliance. The collaboration will be focused on the processing of biological drugs to increase half-life and reduce production costs by using a new PEGylation technology platform. PEGylation is the modification of a protein, peptide or non-peptide molecule by linking polyethylene glycol (PEG) […]
Drug Development Pharma - July 2, 2014
Pelago Bioscience enters agreement with GSK
Pelago Bioscience AB has entered a method licensing agreement with GlaxoSmithKline. The agreement regards the use of the Cellular Thermal Shift Assay for determination and quantification of drug–target interactions. Under the agreement, Pelago Bioscience grants GSK a license to the CETSA method for use in research & development. Pelago Bioscience was spun out from the […]
Clinical Trials - July 2, 2014
Karo Bio granted more Vinnova funding for cancer studies
Karo Bio has been granted another SEK 3.8 million from the Swedish innovation agency Vinnova for the preclinical development of an ERbeta agonist for the treatment of different forms of cancer. The financing is granted through the Forska & Väx program and will be paid out in stages during 2014 and early 2015, to finance studies within […]
Uncategorized - July 1, 2014
Politicians want to double investments in medical research
Six out of ten Swedish parliament candidates believe that doubling the investments in medical research is a good proposition, according to a recent survey. In the election survey conducted with parliament candidates 59 percent says yes to the question on if it’s a good proposition to double the investments in medical research so that they […]
Business Award - July 1, 2014
Sobi receives award
Sobi has been awarded as company of the year at the European Mediscience Awards 2014. The award is given to companies that has achieved recognition from analysts and investors on how the company is run, its financial stability and growth and to companies with a clear strategy on the ambitions regarding its financial, ethical and […]
